| Cvs Pharmacy#11088 | |
| 88 Morgan Street, Jersey City, New Jersey 07302 | |
| (201) 433-3510 |
| Name | Cvs Pharmacy#11088 |
|---|---|
| Organization Name | New Jersey Cvs Pharmacy Llc |
| Location | 88 Morgan Street, Jersey City, New Jersey 07302 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (201) 433-3510 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
RBC Life Sciences, Inc., has been granted US Patent 8357422, which protects its unique dietary supplement formulation that nutritionally supports cognitive function, learning and remembering. The Company markets this supplement under the name "Neurobright."
A new study conducted at the VIB-KU Leuven Center for Cancer Biology in Belgium has labeled the protein Caveolin-1 as a high-potential pursuit in the fight against cancer.
A warning issued by the Food and Drug Administration regarding the use of atypical antipsychotics for the treatment of dementia was associated with a significant decline in the use of these medications for treating dementia symptoms in elderly patients, according to a report in the February issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Epizyme, Inc., a company leading the discovery and development of first-in-class, targeted cancer therapeutics against epigenetic targets, today announced the publication of breakthrough new research in the Proceedings of the National Academy of Sciences (USA). The discovery, centered on the epigenetic enzyme EZH2, illuminates a clear path for the translation of basic science into targeted therapies for the safe and effective treatment of specific forms of human lymphomas.
› Verified 5 days ago
| NPI Number | 1447766761 |
| Organization Name | NEW JERSEY CVS PHARMACY LLC |
| Doing Business As | CVS PHARMACY #11088 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 88 Morgan St, Jersey City, NJ 07302 |
| Phone Number | 201-433-3510 |
News Archive
RBC Life Sciences, Inc., has been granted US Patent 8357422, which protects its unique dietary supplement formulation that nutritionally supports cognitive function, learning and remembering. The Company markets this supplement under the name "Neurobright."
A new study conducted at the VIB-KU Leuven Center for Cancer Biology in Belgium has labeled the protein Caveolin-1 as a high-potential pursuit in the fight against cancer.
A warning issued by the Food and Drug Administration regarding the use of atypical antipsychotics for the treatment of dementia was associated with a significant decline in the use of these medications for treating dementia symptoms in elderly patients, according to a report in the February issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Epizyme, Inc., a company leading the discovery and development of first-in-class, targeted cancer therapeutics against epigenetic targets, today announced the publication of breakthrough new research in the Proceedings of the National Academy of Sciences (USA). The discovery, centered on the epigenetic enzyme EZH2, illuminates a clear path for the translation of basic science into targeted therapies for the safe and effective treatment of specific forms of human lymphomas.
› Verified 5 days ago
News Archive
RBC Life Sciences, Inc., has been granted US Patent 8357422, which protects its unique dietary supplement formulation that nutritionally supports cognitive function, learning and remembering. The Company markets this supplement under the name "Neurobright."
A new study conducted at the VIB-KU Leuven Center for Cancer Biology in Belgium has labeled the protein Caveolin-1 as a high-potential pursuit in the fight against cancer.
A warning issued by the Food and Drug Administration regarding the use of atypical antipsychotics for the treatment of dementia was associated with a significant decline in the use of these medications for treating dementia symptoms in elderly patients, according to a report in the February issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Epizyme, Inc., a company leading the discovery and development of first-in-class, targeted cancer therapeutics against epigenetic targets, today announced the publication of breakthrough new research in the Proceedings of the National Academy of Sciences (USA). The discovery, centered on the epigenetic enzyme EZH2, illuminates a clear path for the translation of basic science into targeted therapies for the safe and effective treatment of specific forms of human lymphomas.
› Verified 5 days ago
Health Aid Drugs Inc Type: Pharmacy Location: 212 Palisade Ave, Jersey City, New Jersey 07306 Phone: (201) 653-1441 | |
Rite Aid Pharmacy 01661 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2859 John F Kennedy Blvd, Jersey City, New Jersey 07306 Phone: (201) 433-2826 | |
Rite Aid Pharmacy 04812 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 981 W Side Ave, Jersey City, New Jersey 07306 Phone: (201) 332-0410 | |
Cvs Pharmacy #17006 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 100 14th St, Jersey City, New Jersey 07310 Phone: (201) 499-0018 | |
Cvs Pharmacy#11088 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 88 Morgan Street, Jersey City, New Jersey 07302 Phone: (201) 433-3510 |